Related Experiment Video
Updated: Dec 21, 2025
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
[Left atrial appendage closure for stroke prevention in atrial fibrillation : An update]
Friederike Zimmermann1, Ulf Landmesser2
1Medizinische Klinik für Kardiologie, Charité - Universitätsmedizin Berlin, Hindenburgdamm 30, 12203, Berlin, Deutschland.
Insights
Atrial fibrillation (AF) patients face high stroke risk. Left atrial appendage (LAA) closure offers an alternative to anticoagulation, showing promise in registry studies despite limited large trial data.
Area of Science:
- Cardiology
- Neurology
- Medical Devices
Background:
- Atrial fibrillation (AF) significantly increases ischemic stroke risk (5-6%/year).
- Current oral anticoagulation (NOAC/VKA) is recommended for high-risk AF patients (CHA2DS2-VASc ≥1).
- Up to 30% of AF patients do not receive effective thromboembolism prophylaxis due to bleeding risks or contraindications.
Purpose of the Study:
- To evaluate Left Atrial Appendage (LAA) closure as an alternative stroke prevention strategy in AF patients.
- To assess the efficacy and safety of catheter-based LAA closure systems.
- To address the limited evidence from large randomized studies impacting guideline recommendations.
Main Methods:
- Review of registry studies on catheter-based LAA closure.
- Analysis of implantation success rates and periprocedural complication rates.
- Comparison with existing oral anticoagulation therapies for stroke prevention in AF.
Main Results:
- Catheter-based LAA closure systems demonstrate high implantation success rates.
- Relatively low periprocedural complication rates were observed in recent registry studies.
- LAA closure provides an alternative for patients unable to tolerate or adhere to anticoagulation.
Conclusions:
- Left Atrial Appendage (LAA) closure is a viable alternative to oral anticoagulation for stroke prevention in AF.
- Further large randomized studies are needed to solidify guideline recommendations for LAA closure.
- Catheter-based LAA closure shows significant potential for improving thromboembolism prophylaxis in AF patients.
Abstract:
Atrial fibrillation (AF) is one of the most frequent causes of ischemic stroke. Without treatment the annual risk of ischemic stroke is on average approximately 5-6%/year in patients with atrial fibrillation, depending on the overall cardiovascular risk profile. Oral anticoagulation with new oral anticoagulants (NOAC) or vitamin K antagonists (VKA) is recommended for patients with AF and an elevated risk for stroke (CHA2DS2-VASc score ≥1); however, severe bleeding complications are potential reasons for discontinuation of this treatment. Overall, up to 30 % of the patients with AF remain without effective thromboembolism prophylaxis. Left atrial appendage (LAA) closure represents an alternative to pharmaceutical stroke prevention. Catheter-based and surgical LAA closure techniques are available. For catheter-based procedures with closure systems, high implantation success rates and relatively low periprocedural complication rates have been observed in recent registry studies. The reason for the restrained recommendation in the European guidelines is the as yet limited experience from large randomized studies.
